FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Guidance on Trivalent Influenza Vaccines

03/10/2006

Federal Register Notice: FDA is making available a draft document entitled Guidance for Industry: Clinical Data Needed to Support ...

Changes for Pediatric Advisory Meeting

03/10/2006

Federal Register Notice: FDA is amending the 2/1 notice of a 3/22 meeting of the Pediatric Advisory Committee to change the starti...

Guidance to Reduce Hospital Bed Entrapment

03/10/2006

Federal Register Notice: FDA is making available a guidance entitled Hospital Bed System Dimensional and Assessment Guidance to Re...

Guidance on Decorporation Products for Radioactivity

03/02/2006

Federal Register Notice: FDA is making available a guidance for industry entitled Internal Radioactive Contamination — Development...

Focus Group Info Sent to OMB

02/27/2006

Federal Register Notice: FDA is submitting a proposed collection of information entitled, "Focus Groups as Used by the Food and Dr...

Guidance on Postmarket Study Status Reports

02/16/2006

Federal Register Notice: FDA is making available a guidance for industry entitled Reports on the Status of Postmarketing Study Com...

Pharmaceutical Science Subcommittee to Meet

02/16/2006

Federal Register Notice: FDA’s Manufacturing Subcommittee of the Advisory Committee for Pharmaceutical Science will meet 4/18-19, ...

Peptavlon Not Withdrawn for S&E

02/10/2006

Federal Register Notice: FDA has determined that Peptavlon (pentagastrin) for subcutaneous injection, 0.25 mg/mL, was not withdraw...

Financial Disclosure Info Sent to OMB

02/10/2006

Federal Register Notice: FDA’s proposed collection of information, "Financial Disclosure by Clinical Investigators — Extension Res...

Info on Petitions Sent to OMB

02/10/2006

Federal Register Notice: FDA’s proposed collection of information, "General Administrative Procedures: Citizen Petitions; Petition...